{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"description":"Feasibility is defined as completion of treatment, which will be reported as a percentage, with a 95% exact confidence interval using the Clopper-Pearson method.","groups":[{"description":"Patients undergo standard of care radiation therapy for a total of 35 fractions over 7 weeks and receive tolinapant PO daily for 7 days during weeks 1, 3, 5, and 7 of radiation therapy in the absence of disease progression or unacceptable toxicity.\n\nTolinapant: Given PO\n\nRadiation Therapy: Undergo radiation therapy","id":"OG000","title":"Treatment (Tolinapant, Radiation Therapy)"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Upon completion of treatment","title":"Feasibility of Tolinapant + Radiation (Number of Patients Able to Complete Treatment)","type":"PRIMARY","unitOfMeasure":"Participants"}